Adalimumab and breast feeding
Limited information indicates that maternal adalimumab injections produce low levels in breastmilk and do not adversely affect the nursing infant. Because adalimumab is a large protein molecule with a molecular weight of about 148,000, absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. Most experts feel that the drug is acceptable to use during nursing. However, until more data become available, adalimumab should be used with caution while nursing a newborn or preterm infant.
Up to date info
Alternative drugs - Adalimumab and breast feeding
Suggested alternatives on Adalimumab and breast feeding, when available and appropriate.
Breast feeding and drugs